Children Behavior Problem

2

Review clinical trials related to Children Behavior Problem. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS)

Language is central to children's cognitive, emotional, and social development, and language difficulties are a frequent reason for consultation in child psychiatry, often co-occurring with psychiatric disorders. Yet, systematic language assessment is rarely possible due to the limited availability of speech-language therapists in these services. The TICOALA tool (Interactive Test of Language Comprehension and Learning on tablet) offers a quick and engaging way to evaluate lexical and syntactic comprehension and word learning. This study aims to assess its acceptability among children aged 3-7 attending a child psychiatry service in Paris, as well as among clinicians and parents. Secondary goals include testing the feasibility of a larger study, describing children's language skills, and examining how these relate to clinical and background variables.

Participants needed: 50
Trial details
Age: 3-7Biological sex: AllType: InterventionalSponsor: Centre Hospitalier St AnneUpdated: Dec 19, 2025
Eligibility criteria

Children (boys or girls) aged 3-7 years [+2]

Inability to use the tablet-based TICOALA tool due to severe sensory (blindness,... [+2]

Status: Recruiting

Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes

This topic puts forward a hypothesis: genetic and environmental factors such as major depressive disorder during pregnancy, nutritional status of vitamin A, D, E, and folic acid, intestinal microecology, and bisphenol A exposure, may affect the cognitive development level of the offspring through the genetic correlation with attention deficit hyperactivity disorder, developmental delay/intellectual disability, and major depressive disorder, allelic heterogeneity and pleiotropy of ITIH3 mediated by SNP and CACNB2, neurotransmitters like dopamine, and metabolic pathways, thereby increasing the risk of attention deficit hyperactivity disorder and developmental delay/intellectual disability prevalence on offspring. This topic planning from allelic heterogeneity and pleiotropy of attention deficit hyperactivity disorder and major depressive disorder mediated by SNP, neurotransmitters like dopamine, and metabolic pathways, explores deeply the influences on children's development level and the risk of common neurological disorder caused by genetic and environmental factors during pregnancy, looking for reasonable prevention, early diagnosis of biomarkers and therapeutic targets, in order to provide data support for further improvement and revision of national mother and infant healthcare policy .

Participants needed: 3,000
Trial details
Age: 3-72Biological sex: AllType: ObservationalSponsor: Chen LiUpdated: Feb 1, 2021Locations: 5Duration: 6 Years
Eligibility criteria

Inclusion criteria for pregnant women: Aged 20~49; [+3]

Patients receiving anti-depression therapy during the first 6 months of gestatio... [+4]